STACEY WHEATLEY: Open Payments
NPI 1629519368 · SHERMAN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,026 in 80 payments from 6 companies in 2025. Trend: 2023 $897 · 2024 $916 · 2025 $2,026
Food & beverage: $2,026
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 54 | $1,184 |
| Gilead Sciences, Inc. | 20 | $697 |
| Merck Sharp & Dohme LLC | 2 | $54 |
| Organon LLC | 2 | $50 |
| Abbott Laboratories | 1 | $24 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $15 |
Products named: DOVATO, CABENUVA, Biktarvy, Yeztugo, APRETUDE, PIFELTRO, NEXPLANON, ETERNA.
Industry payments across TX — which companies pay providers there.
